Prevention of Disabling and Fatal Strokes by Successful Carotid Endarterectomy in Patients Without Recent Neurologic Symptoms: Randomized Controlled Trial
Restricted accessResearch articleFirst published online March, 2005
Prevention of Disabling and Fatal Strokes by Successful Carotid Endarterectomy in Patients Without Recent Neurologic Symptoms: Randomized Controlled Trial
The hazards and medium-term benefits of carotid endarterectomy were studied in patients with substantial carotid artery narrowing but no neurologic symptoms to determine the balance of surgical risks and long-term benefits. Asymptomatic patients were randomized between immediate CEA and indefinite deferral and were followed for 5 years. The number of deaths among those allocated to immediate CEA was non-significantly greater than among those allocated to deferral. Among patients up to 75 years of age, CEA approximately halved the net 5-year risk of stroke, from about 12% to 6%.
1. Executive Committee for the Asymptomatic Carotid Athersclerosis Study: Enidarterectomy for asymnptomatic carotid artery stenosis. JAMA273:1421-1428. 1995.
2.
2. Hobson, RW II, Weiss DG, Fields WS, et al: Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N.Engl J Med328: 221-227, 1993
3.
3. MRC Asymptomratic Carotid Surgery Trial(ACST) Collaborative Group: Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet363:1491-1502, 2004.
